Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jul 19 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-0.19 Insider Own5.38% Shs Outstand89.24M Perf Week3.41%
Market Cap162.94M Forward P/E- EPS next Y-0.06 Insider Trans0.00% Shs Float84.72M Perf Month-2.15%
Income-16.68M PEG- EPS next Q-0.09 Inst Own14.44% Short Float2.07% Perf Quarter-3.19%
Sales36.02M P/S4.52 EPS this Y25.40% Inst Trans-29.75% Short Ratio5.06 Perf Half Y-5.70%
Book/sh0.67 P/B2.73 EPS next Y63.83% ROA-16.85% Short Interest1.76M Perf Year47.97%
Cash/sh1.13 P/C1.61 EPS next 5Y- ROE-25.89% 52W Range0.53 - 3.03 Perf YTD-8.08%
Dividend Est.- P/FCF- EPS past 5Y12.14% ROI-26.75% 52W High-39.94% Beta2.60
Dividend TTM- Quick Ratio4.29 Sales past 5Y94.22% Gross Margin88.60% 52W Low243.40% ATR (14)0.13
Dividend Ex-Date- Current Ratio4.29 EPS Y/Y TTM50.81% Oper. Margin-31.51% RSI (14)47.84 Volatility8.38% 6.79%
Employees68 Debt/Eq0.05 Sales Y/Y TTM380.24% Profit Margin-46.32% Recom1.00 Target Price4.00
Option/ShortYes / Yes LT Debt/Eq0.04 EPS Q/Q24.68% Payout- Rel Volume0.80 Prev Close1.87
Sales Surprise5.53% EPS Surprise27.27% Sales Q/Q- EarningsMay 20 BMO Avg Volume347.50K Price1.82
SMA202.30% SMA50-8.27% SMA2003.64% Trades Volume277,708 Change-2.67%
Date Action Analyst Rating Change Price Target Change
Aug-05-22Downgrade Jefferies Buy → Hold $2
May-26-20Resumed JMP Securities Mkt Outperform $18
May-13-20Initiated Stifel Buy $19
May-07-20Initiated SVB Leerink Outperform
Apr-22-20Initiated ROTH Capital Buy $28
Mar-24-20Initiated SunTrust Buy $16
Jan-16-20Initiated Cantor Fitzgerald Overweight $10
Mar-29-18Initiated Oppenheimer Outperform
Feb-01-16Resumed Oppenheimer Outperform
Oct-15-15Initiated FBR Capital Outperform $14
Jun-17-24 07:00AM
Jun-04-24 09:55AM
May-30-24 07:00AM
May-21-24 08:08AM
May-20-24 11:52AM
08:10AM Loading…
May-16-24 07:00AM
May-15-24 09:57AM
May-06-24 07:00AM
Apr-25-24 07:00AM
Apr-10-24 07:00AM
Apr-03-24 07:00AM
12:00PM Loading…
Mar-12-24 12:00PM
Mar-11-24 07:00AM
Mar-07-24 09:41AM
Mar-06-24 07:00AM
Mar-05-24 11:53AM
Feb-29-24 08:58AM
Feb-26-24 07:00AM
Feb-21-24 12:00PM
Feb-20-24 07:00AM
Feb-15-24 07:00AM
Jan-08-24 07:05AM
Dec-19-23 10:11AM
07:10AM Loading…
Dec-15-23 08:17AM
Dec-05-23 09:40AM
Nov-08-23 04:41PM
Nov-07-23 07:28AM
Nov-06-23 07:00AM
Nov-03-23 04:35PM
Oct-31-23 09:00AM
Oct-24-23 07:00AM
Oct-03-23 07:00AM
Oct-02-23 07:00AM
Sep-27-23 09:00AM
Sep-14-23 09:40AM
Aug-31-23 07:00AM
Aug-29-23 09:40AM
Aug-10-23 12:13PM
Aug-07-23 07:17AM
Jul-24-23 07:00AM
Jul-17-23 07:00AM
Jun-22-23 07:00AM
Jun-13-23 07:00AM
Jun-05-23 07:00AM
Jun-02-23 07:09AM
May-25-23 10:49AM
May-18-23 09:40AM
May-15-23 07:10AM
May-11-23 07:00AM
May-09-23 07:00AM
May-01-23 07:00AM
Apr-27-23 07:00AM
Apr-26-23 07:00AM
Mar-15-23 07:00AM
Mar-14-23 09:40AM
Mar-13-23 06:30AM
Mar-10-23 02:08AM
Mar-08-23 07:00AM
Mar-06-23 07:00AM
Feb-28-23 12:17PM
Feb-27-23 07:00AM
Feb-14-23 07:00AM
Feb-13-23 07:00AM
Feb-09-23 07:00AM
Feb-08-23 05:25PM
Jan-27-23 09:32AM
Jan-23-23 07:00AM
Dec-29-22 04:53PM
Dec-06-22 07:00AM
Dec-01-22 07:00AM
Nov-30-22 04:49PM
Nov-29-22 07:00AM
Nov-17-22 04:51PM
Nov-16-22 07:00AM
Nov-14-22 06:52PM
Nov-08-22 07:00AM
Nov-07-22 08:00AM
Nov-02-22 07:00AM
Nov-01-22 04:41PM
Oct-31-22 07:00AM
Oct-26-22 07:00AM
Oct-06-22 07:00AM
Sep-22-22 07:00AM
Sep-12-22 07:00AM
Sep-07-22 07:00AM
Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses on research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel.